Décret no 2012-1244 du 8 novembre 2012 relatif au renforcement des dispositions en matière de sécurité des médicaments à usage humain soumis à autorisation de mise sur le marché et à la pharmacovigilance

This decree enhances rules for human medicines requiring marketing authorization, focusing on improving their safety. It aims to ensure that medicines available to the public meet high safety standards throughout their lifecycle. The measures affect pharmaceutical companies and healthcare professionals. It strengthens the monitoring of medicines after they are on the market, ensuring quicker responses to potential risks.